What is the potential of gene therapy in regulating insulin secretion or improving pancreatic beta-cell function in diabetes?
Share
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
What is the potential of gene therapy in regulating insulin secretion or improving pancreatic beta-cell function in diabetes?
Gene therapy holds promise for diabetes by potentially restoring normal insulin production in pancreatic beta cells through targeted genetic corrections or enhancements.
Gene therapy could address the autoimmune issues in Type 1 diabetes or help regenerate beta-cell function in Type 2 diabetes by targeting specific genes involved.
By introducing genes that promote insulin production, gene therapy offers a pathway to modify dysfunctional pancreatic cells and manage glucose levels effectively.
Potential gene therapy for diabetes includes using viral vectors to deliver genes that can improve insulin secretion and beta-cell survival, offering a functional restoration approach.